One partner. Across the lifecycle.
Integrated HEOR, real-world evidence and access strategy from early development to post-launch.
Built around your decisions.
HEOR & Value Strategy
Burden of illness, value frameworks, endpoint strategy and evidence synthesis.
Real-World Evidence
Claims, EHR and registry studies; treatment patterns, HCRU and outcomes.
Market Access
Payer research, value dossiers, HTA and evidence strategy.
Economic Modeling
Cost-effectiveness, budget impact and scenario frameworks.
Patient & Provider Research
Surveys, interviews, chart reviews and experience studies.
Digital & Evidence Platforms
Interactive evidence, dashboards and digital strategy.
Where evidence meets complexity.
Policy & Pricing
Medicare negotiation and Medicaid policy-impact evidence.
Rare Disease
Natural history, burden and novel value approaches.
Regulatory Evidence
Trial concepts and endpoint frameworks supporting evidence planning.
Disease Strategy
Epidemiology, unmet need and disease backgrounders.
Scientific Communication
Congress materials and stakeholder evidence narratives.
Data Feasibility
Data selection and study feasibility before full investment.
